PharmTech

JUNE 30, 2025

The company has invested $4 billion in the past 15 years to expand its US operations, which began in 1991, and now has an annual domestic capacity to produce 12 billion finished doses of generic medicines. Hikma Publishes its 2024 Sustainability Report Reinforcing Commitment to Global Access to Medicines. Press Release.

Dosage 59

Dosage Generic Medicine Vaccines 59

European Pharmaceutical Review

JULY 1, 2024

the CHMP gave a positive opinion for the first nasally administered emergency treatment for allergic reactions” A positive opinion was granted to the mResvia (Respiratory Syncytial Virus (RSV) mRNA vaccine). EMA’s human medicines committee decided to revoke the conditional marketing authorisation for Ocaliva. 1 virus variant.

Generic Medicine 106

Generic Medicine Vaccines 106

European Pharmaceutical Review

APRIL 3, 2023

It is the eighth vaccine recommended in the European Union (EU) for COVID-19. The committee adopted a positive opinion for Briumvi (ublituximab) for relapsing multiple sclerosis (MS). It relies partly on results of pre-clinical tests and clinical trials of an already authorised reference product and in part on new data.

Chemotherapy 98

Chemotherapy Vaccines Generic Medicine 98

pharmaphorum

MAY 26, 2022

Factors such as ethnicity, gender, sexual orientation and age can contribute to interindividual differences in treatment responses and risks of adverse events. The race to produce a vaccine which could protect the world against COVID-19 brought the topic of diversity in clinical trials, or lack of it, into sharp focus.

Packaging 143

Packaging Vaccines Generic Medicine Pharmaceutical Companies 143